Wednesday, November 13
Home>>Events>>Live Webinar: Production of Monoclonal Antibodies using Hybridoma Technology

Live Webinar: Production of Monoclonal Antibodies using Hybridoma Technology

Are you interested in immunology research, or do you wish to produce a monoclonal antibody? If yes, this webinar is meant for you!

Learn the basics of hybridoma technology used for antibody production in our upcoming 40 mins live webinar presentation by the expert in this field.


Abstract of the Webinar:

Hybridomas are the cells engineered to produce large amounts of monoclonal antibodies (MAbs) specific to the antigen of interest, a technique popularly known as ‘Hybridoma technology’. For the generation of hybridomas, antigen-specific B lymphocytes must be somatically fused with myeloma cells. MAbs generated using hybridoma technology are being widely used to develop the diagnostics and detection assays (ELISAs, flow cytometry, etc.). Current advancements in hybridoma technology have paved the way to generate humanized MAbs with selective therapeutic properties.


14th February 2019, 11.00 am IST


About the Speaker:

Vishal Khatri

Dr. Vishal Khatri 
Postdoctoral Research Associate
University of Illinois College of Medicine
Rockford, IL-USA

Vishal Khatri completed his doctorate in 2017 from Maharashtra University of Health Sciences, India wherein he worked on the development of helminth based biotherapeutics for immune-mediated disorders. He joined later as Postdoctoral Research Associate at the University of Illinois College of Medicine, Rockford, USA and continues to work there till date. He is currently developing a vaccine for lymphatic filariasis – a tropical parasitic infection that causes a gruesome and disfiguring condition in humans. During his research career, he has earned quite many renowned awards including JRF, SRF, best conference poster and best paper awards, the prestigious Indian Immunology Society Bursary Award and UIC Contribution to Science award.

Join the Webinar here:


Leave a Reply

Your email address will not be published. Required fields are marked *